隐孔菌发酵物对脾虚证哮喘小鼠气道高反应性及炎症的影响

目的建立脾虚证哮喘小鼠模型,观察隐孔菌发酵物(CVFS)对脾虚证哮喘小鼠气道高反应性及炎症的影响。方法以卵白蛋白(OVA)致敏 饮食不节 劳倦过度伤脾法建立脾虚证哮喘小鼠模型;测定小鼠的肺阻力(RL)和支气管-肺泡灌洗液(BALF)中的炎症细胞,观察肺组织和免疫器官脾脏的病理变化。结果脾虚证哮喘小鼠的气道高反应性、BALF中的嗜酸性粒细胞数目,肺组织嗜酸性粒细胞炎性病理变化以及脾脏指数与单纯哮喘小鼠比较有明显差异(P<0.05)。CVFS能明显改善单纯哮喘小鼠和脾虚证哮喘小鼠由乙酰甲胆碱(MCH)诱导的气道高反应性,减少BALF中的嗜酸性粒细胞数目,以及改善肺组织嗜酸性粒细胞炎性病理变化,而对脾虚证哮喘小鼠作用更为明显。CVFS能明显增加脾虚证哮喘小鼠脾脏指数,而对单纯哮喘小鼠的脾脏指数无明显影响。结论OVA致敏 饮食不节 劳倦过度伤脾法可建立脾虚证哮喘小鼠模型;CVFS可明显改善脾虚症状,抑制脾虚证哮喘小鼠的气道高反应性和炎症反应,提示CVFS可用于临床脾虚证哮喘的治疗。

Effects of Cryptoporus volvatus ferment substance on airway hyperresponsiveness and inflammation in asthmatic mice with spleen-deficiency syndrome

Objective To establish a model of asthma mice with spleen-deficiency syndrome (asthma-SDS) and to investigate the effects of Cryptoporus volvatus ferment substance (CVFS) on the airway hyperresponsiveness and inflammation in model mice. Methods An asthma-SDS model of mice was established by ovalbumin (OVA)-sensitized plus over-eating and over-exerting. The changes of lung resistance (R_L), inflammatory cells in bronchoalveolar lavage fluid (BALF), lung tissue pathology, and spleen index were observed. Results Compared with the simple asthma model of mice, the airway hyperresponsiveness, eosinophils number in the BALF, lung tissue pathology, and spleen index in the asthma-SDS model of mice showed a significant difference (P<0.05). CVFS could inhibit methacholine (MCH)-induced airway hyperresponsiveness, decrease eosinophils number in BALF, and improve eosinophils inflammatory infiltration in the lung tissue of the simple asthma and the asthma-SDS model of mice. CVFS had more potent effect in asthma-SDS model than simple asthma model. CVFS also increased spleen index in asthma-SDS model of mice, but not influenced spleen index in simple asthma model. Conclusion An asthma-SDS model of mice could be established by OVA-sensitized plus over-eating and over-exerting. CVFS not only significantly improves spleen-deficiency syndrome in mice, but also inhibits the airway hyperresponsiveness and inflammation in the asthma-SDS model of mice. Consequently, the results suggeste that CVFS could be used for the clinical asthma patients with spleen-deficiency syndrome.